Work

Efficacy and safety of imatinib mesylate (Gleevec®) and immunohistochemical expression of c-Kit and PDGFR-β in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus

Year: 2010

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2010.01.002

Authors: Warner K. Huh, Michael W. Sill, Kathleen M. Darcy, Kevin M. Elias, James S. Hoffman, John F. Boggess, Ronald D. Alvarez, Harry J. Long, David M. O'Malley, Michael J. Birrer

Institutions: University of Alabama at Birmingham, Roswell Park Comprehensive Cancer Center, University at Buffalo, State University of New York, Gynecologic Oncology Group, National Cancer Institute, Center for Cancer Research, Tufts Medical Center, University of North Carolina at Chapel Hill, Mayo Clinic, The Ohio State University

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1340769175, G1950154987, GYNECOLOGIC ONCOLOGY GROUP STATISTICAL AND DATA CENTER, Gynecologic Oncology Group, G70736214

OpenAlex ID: W2140003945

FWCI: 8.757

Cites: 50

Cited by: 40

Related to: 10